Abstract:Cardiovascular diseases (CVD) are common complex diseases caused by the interaction of genetic and environmental factors and are closely related to epigenetic modifications. Recent studies have found that lactylation modification, a newly discovered epigenetic mechanism, regulates histones by adding lactyl groups to lysine residues, thereby promoting the transcription and expression of specific genes. Moreover, it also affects the structure and function of non-histone proteins and plays important roles in the pathogenesis of CVD such as atherosclerosis (As), myocardial infarction (MI), ischemia reperfusion injury (IRI)and heart failure (HF) by regulating protein function and gene expression. In this review, the author summarizes and elaborates on the relevant literature on the roles of lactylation modification in CVD published in recent years, in order to provide reference for future research.